Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Yazar: | Akter, Anika |
---|---|
Diğer Yazarlar: | Alam, Marzia |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2022
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/17039 |
Benzer Materyaller
-
Biologics and Biosimilars as Treatment Options for Psoriasis
Yazar:: Moya, Amena Khatun
Baskı/Yayın Bilgisi: (2023) -
Importance of biologics in rheumatoid arthritis management
Yazar:: Riyadh, S. M.
Baskı/Yayın Bilgisi: (2022) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
Yazar:: Afroza, Halima
Baskı/Yayın Bilgisi: (2024) -
Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
Yazar:: Mehreen, Elnaj
Baskı/Yayın Bilgisi: (2021) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
Yazar:: Islam, Nahidul
Baskı/Yayın Bilgisi: (2023)